Skyward Specialty Insurance Group, Inc.·4

May 8, 4:32 PM ET

Peirce Christopher Locke 4

4 · Skyward Specialty Insurance Group, Inc. · Filed May 8, 2026

Research Summary

AI-generated summary of this filing

Updated

Skyward (SKWD) Director Peirce Locke Receives RSU Award

What Happened Peirce Christopher Locke, a director of Skyward Specialty Insurance Group, Inc. (SKWD), was granted 3,890 restricted stock units (RSUs) on May 6, 2026. The Form 4 reports the acquisition as an award/derivative (code A) at $0.00 per unit; each RSU represents the right to receive one share upon vesting. Under the award terms, the RSUs will fully vest on the date of the Issuer's 2027 Annual Meeting of Shareholders.

Key Details

  • Transaction date: 2026-05-06; Form 4 filed: 2026-05-08 (timely within the usual 2-business-day reporting window).
  • Award: 3,890 RSUs; reported acquisition price $0.00 (derivative award).
  • Shares owned after transaction: Not specified in the provided filing excerpt.
  • Footnotes: F1 — each RSU converts to one share upon settlement; F2 — award granted 5/6/2026 and fully vests at the 2027 Annual Meeting.
  • Transaction code: A (award/grant of derivative securities).

Context RSU grants are a form of equity compensation rather than a cash purchase or sale; they do not represent immediately tradable shares until vesting and settlement. Such awards are common for directors and executives as compensation and do not by themselves signal a buy or sell decision in the open market.

Insider Transaction Report

Form 4
Period: 2026-05-06
Transactions
  • Award

    2026 RSU Award

    [F1][F2]
    2026-05-06+3,8903,890 total
    Common Stock (3,890 underlying)
Holdings
  • Common Stock

    3,200
Footnotes (2)
  • [F1]Each RSU represents the right to receive, after vesting and upon settlement, one share of Common Stock of the Issuer.
  • [F2]On May 6, 2026, the Reporting Person was granted an RSU Award in the amount of 3,890 RSUs. Subject to the terms of the award agreement, this award will fully vest on the date of the Issuer's 2027 Annual Meeting of Shareholders.
Signature
/s/ Stacy E. Skelton, Attorney-in-Fact|2026-05-08

Documents

1 file
  • 4
    form4-05082026_080508.xmlPrimary